Yiwen Liang Selected Research

Yiwen Liang Research Topics

3	Lymphoma (Lymphomas) 04/2024 - 01/2022
3	Graft vs Host Disease (Graft-Versus-Host Disease) 03/2024 - 01/2021
2	Infections 04/2024 - 01/2021
2	Neoplasms (Cancer) 03/2024 - 09/2022
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2023 - 02/2018
1	Abdominal Aortic Aneurysm 04/2024
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2024
1	Weight Loss (Weight Reduction) 04/2024
1	Dyskinesias (Dyskinesia) 04/2024
1	B-Cell Leukemia (Leukemia, B Cell) 04/2024
1	Gout 01/2023
1	Carcinoma (Carcinomatosis) 01/2023
1	Bronchiolitis Obliterans Syndrome 09/2022
1	Cognitive Dysfunction 04/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2022
1	Leukoencephalopathies 04/2022
1	Inflammation (Inflammations) 01/2022
1	Pneumonia (Pneumonitis) 10/2021
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 10/2021
1	Fibrosis (Cirrhosis) 10/2021
1	Connective Tissue Diseases (Connective Tissue Disease) 10/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 10/2021
1	Coronavirus Infections 10/2021
1	Severe Acute Respiratory Syndrome 10/2021
1	Margins of Excision 02/2018

2	Proteins (Proteins, Gene)FDA Link 04/2024 - 09/2022
1	Transcription Factors (Transcription Factor)IBA 04/2024
1	Disks Large Homolog 4 ProteinIBA 04/2024
1	melanin-concentrating hormone (melanin concentrating hormone)IBA 04/2024
1	SugarsIBA 04/2024
1	thrombin receptor peptide (42-47)IBA 03/2024
1	Uric Acid (Urate)IBA 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	Methotrexate (Mexate)FDA LinkGeneric 04/2022
1	IRAK1 inhibitor Jh-X-119-01IBA 01/2022
1	Interleukin-1 Receptor-Associated KinasesIBA 01/2022
1	glucose utilization inhibitor (IGU)IBA 10/2021
1	iguratimodIBA 10/2021
1	N-acetyltalosaminuronic acid (NAT)IBA 10/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2021
1	CollagenIBA 10/2021
1	Bleomycin (Blenoxane)FDA LinkGeneric 10/2021
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 10/2021
1	Interleukin-22 (IL-22)IBA 01/2021